50.19. Analysis.
Comparison 50 HA/hylan versus placebo, Outcome 19 Safety: number of adverse events probably or possibly related to treatment.
Comparison 50 HA/hylan versus placebo, Outcome 19 Safety: number of adverse events probably or possibly related to treatment.